HEMOGLOBINOPATHY
Clinical trials for HEMOGLOBINOPATHY explained in plain language.
Never miss a new study
Get alerted when new HEMOGLOBINOPATHY trials appear
Sign up with your email to follow new studies for HEMOGLOBINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Milder chemo may make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowThis phase 2 trial tests a combination of three chemotherapy drugs (treosulfan, fludarabine, thiotepa) plus an immune-suppressing antibody before a donor stem cell transplant in up to 40 people under 50 with non-cancerous blood disorders. The goal is to see if this milder conditi…
Matched conditions: HEMOGLOBINOPATHY
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Gene therapy Follow-Up: 15-Year watch for sickle cell patients
Disease control Recruiting nowThis long-term follow-up study tracks 50 patients with sickle cell disease who received the experimental gene therapy BEAM-101. The goal is to monitor safety, side effects, and overall health for up to 15 years after treatment. Participants will have regular check-ups to see how …
Matched conditions: HEMOGLOBINOPATHY
Sponsor: Beam Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
How long do red blood cells live? new study uses biotin to find out
Knowledge-focused Recruiting nowThis study aims to measure how long red blood cells survive in people with sickle cell disease, thalassemia, and other inherited blood disorders. Researchers will take a blood sample, label the red cells with biotin (a vitamin), and infuse them back into the participant. Over up …
Matched conditions: HEMOGLOBINOPATHY
Phase: EARLY_PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC